Eidos Therapeutics
|
15.7 |
$30M |
|
225k |
131.58 |
Spdr S&p 500 Etf Trust Trust Tr Unit Put Option
(SPY)
|
7.9 |
$15M |
|
40k |
373.88 |
Curis
|
6.3 |
$12M |
|
1.5M |
8.19 |
Bridgebio Pharma
(BBIO)
|
5.8 |
$11M |
|
155k |
71.11 |
Kura Oncology
(KURA)
|
4.5 |
$8.5M |
|
260k |
32.66 |
Vincera Pharma
(VINC)
|
4.5 |
$8.4M |
|
403k |
20.91 |
Rocket Pharmaceuticals
(RCKT)
|
3.1 |
$5.8M |
|
105k |
54.84 |
Acceleron Pharma
|
3.1 |
$5.8M |
|
45k |
127.93 |
Ocular Therapeutix
(OCUL)
|
2.4 |
$4.6M |
|
220k |
20.70 |
Cerevel Therapeutics Hldng I
(CERE)
|
2.4 |
$4.5M |
|
270k |
16.58 |
Sutro Biopharma
(STRO)
|
2.3 |
$4.3M |
|
200k |
21.71 |
Retrophin Note 2.500 9/15/2025 (Principal)
|
2.1 |
$4.0M |
|
4.0M |
1.01 |
Ark Etf Tr Genomic Rev Etf Put Option
(ARKG)
|
2.0 |
$3.7M |
|
40k |
93.25 |
Immunovant
(IMVT)
|
1.8 |
$3.5M |
|
75k |
46.19 |
Syndax Pharmaceuticals Call Option
(SNDX)
|
1.8 |
$3.3M |
|
151k |
22.24 |
Horizon Therapeutics SHS
|
1.7 |
$3.3M |
|
45k |
73.16 |
Arya Sciences Acquisition Com Cl A
|
1.7 |
$3.3M |
|
300k |
10.85 |
Lifesci Acquisition Ii Corp
|
1.7 |
$3.2M |
|
300k |
10.67 |
Zymeworks
|
1.6 |
$3.1M |
|
65k |
47.26 |
Axsome Therapeutics Call Option
(AXSM)
|
1.5 |
$2.9M |
|
35k |
81.48 |
Health Sciences Acquisitions Corp 2 Ord Shs
|
1.4 |
$2.6M |
|
200k |
12.81 |
Chinook Therapeutics
|
1.3 |
$2.4M |
|
150k |
15.86 |
Vertex Pharmaceuticals Incorporated
(VRTX)
|
1.3 |
$2.4M |
|
10k |
236.30 |
Morphic Hldg
(MORF)
|
1.2 |
$2.3M |
|
68k |
33.56 |
Mereo Biopharma Group Ads
(MREO)
|
1.2 |
$2.2M |
|
625k |
3.58 |
Athenex
|
1.2 |
$2.2M |
|
200k |
11.06 |
Mirati Therapeutics
|
1.2 |
$2.2M |
|
10k |
219.60 |
Global Blood Therapeutics In
|
1.1 |
$2.2M |
|
50k |
43.32 |
Leap Therapeutics
|
1.1 |
$2.0M |
|
905k |
2.25 |
Solid Biosciences Call Option
|
1.0 |
$1.9M |
|
250k |
7.58 |
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
0.9 |
$1.7M |
|
10k |
166.80 |
Meiragtx Holdings
(MGTX)
|
0.8 |
$1.5M |
|
100k |
15.14 |
Longview Acquisition Corp Com Cl A
|
0.8 |
$1.5M |
|
75k |
19.79 |
Cytokinetics
(CYTK)
|
0.8 |
$1.5M |
|
70k |
20.79 |
Pulmonx Corp
(LUNG)
|
0.7 |
$1.4M |
|
20k |
69.00 |
Mersana Therapeutics
(MRSN)
|
0.7 |
$1.3M |
|
50k |
26.62 |
Celldex Therapeutics
(CLDX)
|
0.7 |
$1.3M |
|
75k |
17.52 |
Pandion Therapeutics
|
0.6 |
$1.2M |
|
80k |
14.85 |
Bctg Acquisition Corp
|
0.6 |
$1.1M |
|
100k |
11.44 |
Vesper Healthcare Acquisition Corp Com Cl A
|
0.6 |
$1.1M |
|
100k |
11.31 |
Cyclacel Pharmaceuticals
|
0.5 |
$918k |
|
118k |
7.81 |
Beyondspring SHS
(BYSI)
|
0.5 |
$915k |
|
75k |
12.20 |
Iovance Biotherapeutics
(IOVA)
|
0.5 |
$909k |
|
20k |
46.38 |
Dicerna Pharmaceuticals
|
0.5 |
$881k |
|
40k |
22.02 |
Inari Medical Ord
(NARI)
|
0.5 |
$873k |
|
10k |
87.30 |
Kalvista Pharmaceuticals
(KALV)
|
0.5 |
$855k |
|
45k |
19.00 |
Vaxcyte
(PCVX)
|
0.4 |
$797k |
|
30k |
26.57 |
Chardan Healthcr Acqstn 2
|
0.4 |
$794k |
|
75k |
10.59 |
Immatics *w Exp 07/01/2025
(IMTXW)
|
0.4 |
$699k |
|
243k |
2.88 |
Sio Gene Therapies Common
|
0.4 |
$695k |
|
250k |
2.78 |
Aldeyra Therapeutics
(ALDX)
|
0.4 |
$686k |
|
100k |
6.86 |
C4 Therapeutics Com Stk
(CCCC)
|
0.4 |
$663k |
|
20k |
33.15 |
Vincera Pharma *w Exp 12/24/2025
|
0.3 |
$627k |
|
190k |
3.30 |
Lyra Therapeutics
(LYRA)
|
0.3 |
$570k |
|
50k |
11.40 |
Outset Med
(OM)
|
0.3 |
$568k |
|
10k |
56.80 |
Madrigal Pharmaceuticals
(MDGL)
|
0.3 |
$556k |
|
5.0k |
111.20 |
Crispr Therapeutics Namen Akt
(CRSP)
|
0.3 |
$536k |
|
3.5k |
153.14 |
Cerevel Therapeutics Holdings I *w Exp 06/09/2025
(CEREW)
|
0.2 |
$409k |
|
73k |
5.64 |
Vaxart Com New Put Option
(VXRT)
|
0.1 |
$143k |
|
25k |
5.72 |
Vesper Healthcare Acquisition Corp *w Exp 09/30/2027
|
0.0 |
$88k |
|
33k |
2.64 |
Zynerba Pharmaceuticals
|
0.0 |
$44k |
|
13k |
3.31 |